Futura Medical (LON:FUM) Trading 1.4% Higher – What’s Next?

Futura Medical plc (LON:FUM) was up 1.4% during trading on Tuesday . The company traded as high as GBX 0.25 and last traded at GBX 0.21. 162,214,766 shares were traded during mid-day trading, an increase of 1,507% from the average daily volume of 10,092,442 shares. The stock had previously closed at GBX 0.21.

Futura Medical Stock Performance

The firm has a market capitalization of £1.24 million, a PE ratio of -0.26 and a beta of 0.02. The business’s fifty day simple moving average is GBX 0.40 and its 200-day simple moving average is GBX 0.76.

Futura Medical (LON:FUM) last issued its earnings results on Tuesday, September 1st. The company reported GBX (0.20) earnings per share for the quarter. Futura Medical had a negative return on equity of 152.42% and a negative net margin of 158.21%. Sell-side analysts expect that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.